查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1983920

毒性测试外包市场：按服务供应商、测试模型和最终用户划分－2026-2032年全球市场预测

Toxicity Testing Outsourcing Market by Service Provider, Test Model, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，毒理学测试外包市场价值将达到 47.1 亿美元，到 2026 年将成长至 51.4 亿美元，到 2032 年将达到 88.3 亿美元，复合年增长率为 9.39%。

主要市场统计数据
基准年 2025 47.1亿美元
预计年份：2026年 51.4亿美元
预测年份 2032 88.3亿美元
复合年增长率 (%) 9.39%

这本权威的入门书籍概述了将毒性测试外包的必要性，并提出了研发和采购部门领导者面临的关键策略挑战。

全球毒性测试外包格局正在经历结构性和策略性的重组，这要求企业主管重新评估与供应商的关係、技术能力和合规体系。在对专业知识、可扩展的处理能力和快速排期的需求驱动下，许多机构正从纯粹的内部测试模式转向混合模式，即与学术实验室建立合作关係并与合约研究组织 (CRO) 签订合约。实际上，这种转变需要对供应商在不同测试模式下的能力进行严格评估，包括电脑辅助的电脑In Silico方法、靶向体外研究和成熟的体内研究，同时还要考虑伦理、监管和声誉因素。

技术成熟度、一体化 CRO 服务模式以及与学术机构的合作如何改变毒性测试的外包模式？

外包毒性测试的格局正因技术进步、监管期望的改变以及组织优先事项的调整而重塑。计算毒理学已从一项小众技术发展成为主流战略工具。生理药物动力学（PBPK）建模和定量构效关係（QSAR）方法现已常规应用于早期风险评估，从而减少了对资源密集型湿实验室工作的依赖。同时，体外细胞毒性、遗传毒性、内毒素和光毒性测试方法在可重复性和处理能力方面日益成熟，从而能够更早地做出决策并简化后续流程。伴随这些技术变革，营运模式也正在转变。合约研究组织（CRO）正在扩展其服务范围，以提供整合计划管理、集中式资料平台和统一的品质体系，从而简化向多个司法管辖区的监管机构提交报告的流程。

评估美国于 2025 年推出的关税变化对营运和供应链的影响，以及实验室和赞助商如何适应。

美国将于2025年实施的新关税为毒性测试供应链和服务交付带来了新的复杂性。特种试剂、实验室设备和分析耗材的进口成本增加，推高了采购成本，迫使实验室重新评估筹资策略并实现供应商多元化。为此，许多服务供应商和学术合作伙伴正在地采购关键供应组件，重新谈判供应商合同，探索替代材料，并简化流程，以在保持测试完整性的同时缓解成本压力。这些调整对计划进度和供应商选择标准产生了连锁反应，促使专案发起人优先考虑那些在不影响资料品质的前提下成功实施替代材料，并已证明其供应链具有韧性的供应商。

将供应商类型、最终用户行业特征和测试模型选择联繫起来的关键细分信息，有助于供应商选择和项目设计。

细分市场分析揭示了不同服务提供者类型、终端用户类别和首选检测模型之间的微妙需求驱动因素和服务期望，这些因素应指南个人商业策略。基于服务供应商，市场可细分为学术实验室和合约研究组织 (CRO)，二者提供互补价值。学术实验室通常主导方法创新和早期检测检验，而 CRO 则提供规模化、合规营运和一体化计划执行。从终端用户来看，农药、生技、化学、化妆品、食品饮料和製药等产业的需求流各不相同。在这些产业内部，化肥製造商与农药製造商、Start-Ups、通用化学品製造商与特种化学品製造商、彩妆品与护肤护髮产品、饮料製造商与乳製品和加工食品製造商、学名药製造商与大型製药公司等细分市场，影响着服务范围、监管审查和时间表。基于检测模型，可选择的方案包括In Silico、体外和体内检测。In Silico能力（包括 PBPK 和 QSAR 建模）正日益为可行性决策做出贡献；体外试验（如细胞毒性、内毒素、基因毒性和光毒性测试）可深入了解标靶机制；体内策略依赖替代动物模型以及非囓齿类和囓齿类模型，其中存在伦理和监管要求。

美洲、欧洲、中东和非洲以及亚太地区的营运、监管和产能趋势，以及它们对外包策略和风险管理的影响。

区域趋势持续对毒性测试生态系统中的营运策略、监管合规性和供应商选择产生关键影响。在美洲，测试能力的集中、成熟的法规结构以及接近性主要製药和生物技术中心的优势，有利于快速开展临床应用并确保测试的高合规性；然而，计划也面临关税和物流波动风险，因此需要製定完善的紧急时应对计画。在欧洲、中东和非洲，监管的多样性和日益完善的伦理标准促进了替代模式和统一测试通讯协定的采用。同时，拥有卓越学术水平的本地研究中心为专业检测方法的开发和合作检验提供了机会。在亚太地区，实验室基础设施的大量投资、CRO规模的扩大以及具有竞争力的成本趋势，为外包提供了极具吸引力的选择，尤其适用于大量测试。然而，申办方必须谨慎应对监管预期、数据标准和供应链可追溯性方面的差异。

服务供应商如何透过整合科学能力、数位平台和供应链韧性来实现差异化，并满足赞助商的复杂需求。

服务供应商之间的竞争格局和能力正在迅速变化，各公司正增加对专业化、数位化平台和整合服务模式的投资，以满足申办方日益复杂的需求。领先的合约研究组织 (CRO) 正在扩展其体外实验组合和In Silico能力，提供结合计算科学和湿实验室的综合服务包，同时加强品管体系，以方便向跨国监管机构提交申请。学术实验室正在加强与产业界的转化伙伴关係，提供新型检测方法和专业知识，以降低早期研发阶段面临的风险。同时，供应商在提供减少行政摩擦的服务方面也日益注重差异化，例如资料互通性、电子资料收集 (EDC) 框架以及标准化测试范本和统一报告格式。

为高阶主管提供调整筹资策略、建立监督结构以及加强外包测试的供应链和资料管治的实用建议。

产业领导者应采取务实且优先的措施，在最大限度利用外包机会的同时，降低营运和监管风险。首先，企业应制定以细分市场主导的采购策略，将供应商的优势与特定的最终用户需求和测试模型要求相匹配，从而在整个产品系列中实现可重复且合理的供应商选择。其次，企业应投资加强内部监管能力，例如提高生理药物动力学 (PBPK) 和定量构效关係 (QSAR) 解读能力、分析方法转换管理能力以及合约品质指标的执行能力。这可以确保第三方伙伴关係能够补充而非取代内部专业知识。此外，采购和研发团队应执行严格的供应链实质审查程序，以评估试剂依赖性、单一来源风险以及应对关税变化相关波动的紧急时应对计画。

严谨、多方面的研究途径，结合专家访谈、供应商比较和情境分析，确保提供令人信服且可操作的见解。

本研究采用多面向调查方法，结合质性专家访谈、能力比较评估和主题整合，以得出可操作的见解。主要资讯来源包括对农药、生物技术、化工、化妆品、食品饮料和製药等行业研发、监管和采购部门高级领导的结构化访谈，以及与学术实验室和商业合约研究机构（CRO）的科学主任的讨论。二级资讯来源包括关于检测方法验证和替代模型的同行评审文献、监管指导文件和公开的企业资讯披露，从而对供应商的能力和服务产品进行多方面的检验。分析方法包括交叉细分映射，以将供应商类型与最终用户需求和测试模型适用性相匹配，以及情境分析，以评估收费系统和供应链应急计画。

对策略性外包、调查方法创新和供应链完整性如何整合以塑造未来毒性测试计划进行综合和总结性分析。

总之，毒性测试外包生态系统正处于一个转折点，其特征是技术融合、供应链监管加强以及申办者期望不断提高。计算毒理学和可靠的体外方法正在重塑早期决策，而合约研究机构 (CRO) 和学术实验室正在演变为互补角色，可以携手合作以加速研发并管理监管风险。关税相关的波动增加了对供应链透明度和区域产能规划的需求，促使申办方优先选择那些拥有成熟物流韧性和灵活采购惯例的供应商。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：按服务提供者分類的毒性测试外包市场

  • 学术研究机构
  • 合约研究机构

第九章：依测试模型分類的毒性测试外包市场

  • In Silico
    • PBPK建模
    • QSAR建模
  • 体外
    • 细胞毒性试验
    • 内毒素试验
    • 基因毒性测试
    • 光毒性试验
  • In vivo
    • 替代动物模型
    • 非囓齿类动物模型
    • 囓齿动物模型

第十章：毒性测试外包市场：依最终用户划分

  • 杀虫剂
    • 化肥生产商
    • 农业化学品製造商
  • 生物技术
    • 一家历史悠久的生物技术公司
    • 生技新兴企业
  • 化学
    • 通用化学品製造商
    • 特种化学品製造商
  • 化妆品
    • 彩妆品
    • 护髮产品
    • 护肤
  • 食品/饮料
    • 饮料製造商
    • 乳製品生产商
    • 加工食品製造商
  • 製药
    • 学名药
    • 大型製药企业

第十一章：毒性测试外包市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十二章：毒性测试外包市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十三章：毒性测试外包市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章：美国毒理学检测外包市场

第十五章：中国毒理学检测外包市场

第十六章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • ALS Limited
  • Altasciences Corporation
  • BioReliance
  • Charles River Laboratories International, Inc.
  • Cyprotex
  • Eurofins Scientific SE
  • Evotec SE
  • Frontage Laboratories, Inc.
  • GenScript Biotech Corporation
  • ICON plc
  • Inotiv, Inc.
  • Intertek Group plc
  • IQVIA Inc.
  • Laboratory Corporation of America Holdings
  • Lonza Group Ltd.
  • Parexel International Corporation
  • PAREXEL International Corporation
  • PPD, Inc.
  • Promega Corporation
  • SGS SA
  • Syngene International Limited
  • Toxikon Corporation
  • WuXi AppTec Co., Ltd.
Product Code: MRR-1D39DE28BC82

The Toxicity Testing Outsourcing Market was valued at USD 4.71 billion in 2025 and is projected to grow to USD 5.14 billion in 2026, with a CAGR of 9.39%, reaching USD 8.83 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.71 billion
Estimated Year [2026] USD 5.14 billion
Forecast Year [2032] USD 8.83 billion
CAGR (%) 9.39%

An authoritative introduction framing the outsourcing imperative in toxicity testing and the pivotal strategic questions confronting research and procurement leaders

The global environment for toxicity testing outsourcing is undergoing a structural and strategic recalibration that requires senior leaders to reassess supplier relationships, technical capabilities, and compliance postures. Many organizations are shifting away from purely internal testing paradigms toward hybrid models that mix academic laboratory partnerships and contract research organization engagements, driven by the need for specialized expertise, scalable throughput, and accelerated timelines. In practice, this transition calls for a rigorous evaluation of provider competency across diverse test models, including computational in silico approaches, targeted in vitro assays, and established in vivo studies, while also weighing ethical, regulatory, and reputational considerations.

Consequently, decision-makers must reconcile scientific rigor with commercial pragmatism. Procurement teams and R&D leaders are now defining new governance frameworks that codify quality expectations, data provenance, and cross-border operational continuity. As such, this introduction frames the critical strategic questions that follow: how to select the right mix of service providers, how to align test model choices with product development imperatives, and how to structure partnerships that preserve regulatory defensibility without sacrificing speed. This foundational perspective sets the stage for a deeper examination of the transformative shifts, tariff influences, segmentation insights, and actionable recommendations contained within the report.

How technological maturation, integrated CRO service models, and collaborative academic partnerships are reshaping the toxicity testing outsourcing paradigm

The landscape of outsourced toxicity testing is being redefined by converging technological advances, evolving regulatory expectations, and shifting organizational priorities. Computational toxicology has moved from a niche capability to a mainstream strategic lever; PBPK modeling and QSAR approaches now routinely inform early risk assessment and reduce reliance on resource-intensive wet-lab work. At the same time, in vitro methods such as cytotoxicity, genotoxicity, endotoxin, and phototoxicity testing have matured in reproducibility and throughput, enabling earlier decisions and streamlined downstream programs. These technical shifts have been paralleled by operational transformations: contract research organizations are expanding service portfolios to offer integrated project management, centralized data platforms, and harmonized quality systems that facilitate multi-jurisdictional regulatory submissions.

Moreover, academic laboratories remain an important source of niche expertise and novel assay development, often collaborating with industry to validate emergent methods. As organizations adopt blended sourcing strategies, they must also contend with talent mobility, data interoperability, and the need for standardized performance metrics. In short, the transformative shifts are not limited to technology; they encompass commercial models, data governance, and cross-sector collaborations that will determine which providers and partnerships create enduring value for sponsors.

Assessing the operational and supply chain ramifications of the United States tariff changes introduced in 2025 and how laboratories and sponsors are adapting

The introduction of new United States tariff measures in 2025 has introduced a new vector of complexity for toxicity testing supply chains and service delivery. Increased import costs for specialized reagents, laboratory instrumentation, and analytical consumables have elevated procurement spend and prompted laboratories to reassess sourcing strategies and supplier diversification. In response, many service providers and academic partners have begun to localize critical supply components, renegotiate supplier contracts, and explore alternative materials or process efficiencies to preserve test integrity while moderating cost pressures. These adjustments are having cascading effects on project timelines and vendor selection criteria, encouraging sponsors to favor providers with proven supply chain resilience and demonstrated capacity to onboard alternative inputs without compromising data quality.

In parallel, cross-border specimen and data transfer protocols have been subject to heightened scrutiny as organizations work to balance tariff-induced cost impacts with regulatory export controls and data protection requirements. As a result, sponsors are increasingly valuing end-to-end transparency in vendor logistics and contingency planning. Over time, the tariff environment has accelerated the industry's focus on vertical integration, regional laboratory expansion, and strategic inventory management, making supply chain due diligence a central component of toxicity testing outsourcing decisions.

Critical segmentation intelligence linking provider type, end-user industry nuances, and test-model selection to inform supplier selection and program design

Segmentation analysis reveals nuanced demand drivers and service expectations across provider types, end-user categories, and test-model preferences that should guide tailored commercial strategies. Based on service provider, the market is differentiated between academic laboratories and contract research organizations, with each segment delivering complementary value: academic labs frequently drive methodological innovation and early-stage assay validation, while CROs offer scale, regulated operations, and integrated project execution. Based on end user, demand flows vary across agrochemical, biotechnology, chemical, cosmetic, food and beverage, and pharmaceutical sectors; within these industries, sub-segments such as fertilizer versus pesticide manufacturers, established biotechnology firms versus start-ups, commodity versus specialty chemical producers, color cosmetics versus skin and hair care lines, beverage versus dairy and processed food manufacturers, and generic versus large pharmaceutical companies shape service scope, regulatory intensity, and timetables. Based on test model, choices span in silico, in vitro, and in vivo approaches, where in silico capabilities including PBPK and QSAR modeling increasingly inform go/no-go decisions, in vitro assays such as cytotoxicity, endotoxin, genotoxicity and phototoxicity testing provide targeted mechanistic insight, and in vivo strategies rely on alternative animal models as well as nonrodent and rodent models where ethically and regulatorily necessary.

By integrating these segmentation axes, sponsors can design sourcing strategies that align provider capabilities with product lifecycle stage, regulatory context, and risk tolerance. For instance, early-stage biotech firms often benefit from partnerships that combine academic innovation with CRO operationalization, while large pharmaceutical companies typically prioritize high-volume regulated delivery alongside advanced in silico support. Consequently, segmentation-aware supplier evaluation and contract design improve alignment between scientific needs and commercial outcomes.

Regional operational, regulatory, and capacity dynamics across the Americas, EMEA, and Asia-Pacific and their implications for outsourcing strategy and risk management

Regional dynamics continue to exert a determinative influence on operational strategy, regulatory navigation, and vendor selection in the toxicity testing ecosystem. In the Americas, capacity concentration, mature regulatory frameworks, and proximity to major pharmaceutical and biotech hubs favor rapid clinical translation and high-compliance testing, but also expose projects to tariff and logistics variability that require robust contingency plans. In Europe, the Middle East and Africa region, regulatory heterogeneity and advancing ethical standards encourage adoption of alternative models and harmonized testing protocols, while local centers of excellence in academic research offer specialized assay development and collaborative validation opportunities. In the Asia-Pacific region, significant investments in laboratory infrastructure, growing CRO scale, and competitive cost dynamics create attractive outsourcing options, particularly for high-volume testing, though sponsors must carefully manage differences in regulatory expectations, data standards, and supply chain traceability.

As organizations evaluate regional sourcing, they increasingly prioritize providers with transparent quality systems, cross-border compliance expertise, and demonstrable logistical resilience. Strategic decisions about where to place studies are therefore informed by an interplay of scientific requirements, regulatory timelines, and operational risk tolerance, making regional insight an indispensable component of vendor selection and program planning.

How service providers are differentiating through integrated scientific capabilities, digital platforms, and supply chain resilience to meet complex sponsor needs

Competitive and capability landscapes among service providers are evolving rapidly as companies invest in specialization, digital platforms, and integrated service models to meet increasingly sophisticated sponsor demands. Leading contract research organizations are expanding in vitro portfolios and in silico capabilities to offer combined computational and wet-lab packages, while also reinforcing quality management systems to facilitate multi-jurisdictional regulatory submissions. Academic laboratories are strengthening translational partnerships with industry, providing access to novel assays and specialized expertise that can de-risk early development questions. At the same time, vendor differentiation is emerging around data interoperability, electronic data capture frameworks, and offerings that reduce administrative friction, such as standardized study templates and harmonized reporting formats.

Strategic buyers should evaluate providers not only on technical performance but also on demonstrable investments in supply chain resilience, regulatory intelligence, and client-centric project governance. Partnerships with vendors who offer predictive analytics for project scheduling, validated alternative assay workflows, and transparent reagent sourcing will become increasingly valuable. In addition, collaboration models that embed knowledge transfer, capacity-building, and shared quality metrics can accelerate sponsor self-sufficiency while maintaining access to specialized capabilities when needed.

Actionable recommendations for executives to align sourcing strategies, build oversight capabilities, and strengthen supply chain and data governance in outsourced testing

Industry leaders should adopt a pragmatic, prioritized set of actions to capitalize on outsourcing opportunities while mitigating operational and regulatory risks. First, organizations should formalize a segmentation-driven sourcing playbook that maps provider strengths to specific end-user needs and test-model requirements, enabling repeatable and defensible vendor selection across product portfolios. Next, firms must invest in in-house competencies that enhance oversight-such as proficiency in PBPK and QSAR interpretation, assay transfer management, and contractual quality metrics-so that third-party partnerships complement rather than substitute internal expertise. Additionally, procurement and R&D teams should enforce stringent supply chain due diligence protocols that assess reagent dependency, single-source risks, and contingency plans in the face of tariff-driven volatility.

Furthermore, organizations should negotiate data and IP clauses that preserve analytical transparency and ensure long-term access to study outputs. They should also pilot hybrid engagement models that combine academic innovation with CRO operationalization to accelerate validation of alternative methods while maintaining regulatory robustness. Lastly, leadership should embed continuous improvement processes that track provider performance over time, incorporate learnings into subsequent study design, and refine governance structures to support scalable outsourcing across geographies and therapeutic areas.

A rigorous multi-method research approach combining expert interviews, comparative provider assessments, and scenario analysis to ensure defensible and actionable findings

This research employed a multi-pronged methodology combining qualitative expert interviews, comparative capability assessment, and thematic synthesis to produce actionable insights. Primary inputs included structured interviews with senior R&D, regulatory, and procurement leaders across agrochemical, biotechnology, chemical, cosmetic, food and beverage, and pharmaceutical sectors, as well as discussions with scientific directors from academic laboratories and commercial CROs. Secondary sources encompassed peer-reviewed literature on assay validation and alternative models, regulatory guidance documents, and publicly available company disclosures to triangulate provider capabilities and service offerings. Analytical methods included cross-segmentation mapping to align provider types with end-user requirements and test-model fit, as well as scenario analysis to evaluate tariff and supply chain contingencies.

To ensure rigor, the research applied consistent evaluation criteria across technical validity, operational scalability, regulatory readiness, and supply chain resilience. Findings were validated through iterative stakeholder feedback sessions and refined to reflect real-world constraints and best practices. This methodological approach supports reproducibility and provides a defensible basis for the strategic recommendations and segmentation insights presented in the report.

Synthesis and final reflections on how strategic outsourcing, methodological innovation, and supply chain integrity converge to shape future toxicity testing programs

In conclusion, the toxicity testing outsourcing ecosystem is at an inflection point defined by technological convergence, heightened supply chain scrutiny, and increasingly sophisticated sponsor expectations. Computational toxicology and robust in vitro methods are reshaping early decision-making, while contract research organizations and academic laboratories are evolving complementary roles that can be orchestrated to accelerate development and manage regulatory risk. Tariff-related disruptions have intensified the need for supply chain transparency and regional capability planning, prompting sponsors to prioritize vendors with demonstrated logistical resilience and adaptive sourcing practices.

Ultimately, organizations that adopt segmentation-aware sourcing, build internal oversight in critical scientific domains, and pursue strategic partnerships that blend innovation with operational rigor will be best positioned to extract value from outsourced testing. By focusing on data interoperability, validated alternative methods, and contractual frameworks that preserve access to study outputs, leaders can reduce program risk and enhance agility. The recommendations and insights provided herein offer a practical roadmap for navigating immediate challenges while building long-term resilience in toxicity testing programs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Toxicity Testing Outsourcing Market, by Service Provider

  • 8.1. Academic Laboratories
  • 8.2. Contract Research Organization

9. Toxicity Testing Outsourcing Market, by Test Model

  • 9.1. In Silico
    • 9.1.1. PBPK Modeling
    • 9.1.2. QSAR Modeling
  • 9.2. In Vitro
    • 9.2.1. Cytotoxicity Testing
    • 9.2.2. Endotoxin Testing
    • 9.2.3. Genotoxicity Testing
    • 9.2.4. Phototoxicity Testing
  • 9.3. In Vivo
    • 9.3.1. Alternative Animal Models
    • 9.3.2. Nonrodent Models
    • 9.3.3. Rodent Models

10. Toxicity Testing Outsourcing Market, by End User

  • 10.1. Agrochemical
    • 10.1.1. Fertilizer Manufacturers
    • 10.1.2. Pesticide Manufacturers
  • 10.2. Biotechnology
    • 10.2.1. Established Biotechnology Firms
    • 10.2.2. Start-Up Biotechnology Firms
  • 10.3. Chemical
    • 10.3.1. Commodity Chemical Manufacturers
    • 10.3.2. Specialty Chemical Manufacturers
  • 10.4. Cosmetic
    • 10.4.1. Color Cosmetic
    • 10.4.2. Hair Care Products
    • 10.4.3. Skin Care
  • 10.5. Food And Beverage
    • 10.5.1. Beverage Manufacturers
    • 10.5.2. Dairy Product Manufacturers
    • 10.5.3. Processed Food Manufacturers
  • 10.6. Pharmaceutical
    • 10.6.1. Generic Pharma
    • 10.6.2. Large Pharma

11. Toxicity Testing Outsourcing Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Toxicity Testing Outsourcing Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Toxicity Testing Outsourcing Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Toxicity Testing Outsourcing Market

15. China Toxicity Testing Outsourcing Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. ALS Limited
  • 16.6. Altasciences Corporation
  • 16.7. BioReliance
  • 16.8. Charles River Laboratories International, Inc.
  • 16.9. Cyprotex
  • 16.10. Eurofins Scientific SE
  • 16.11. Evotec SE
  • 16.12. Frontage Laboratories, Inc.
  • 16.13. GenScript Biotech Corporation
  • 16.14. ICON plc
  • 16.15. Inotiv, Inc.
  • 16.16. Intertek Group plc
  • 16.17. IQVIA Inc.
  • 16.18. Laboratory Corporation of America Holdings
  • 16.19. Lonza Group Ltd.
  • 16.20. Parexel International Corporation
  • 16.21. PAREXEL International Corporation
  • 16.22. PPD, Inc.
  • 16.23. Promega Corporation
  • 16.24. SGS SA
  • 16.25. Syngene International Limited
  • 16.26. Toxikon Corporation
  • 16.27. WuXi AppTec Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL TOXICITY TESTING OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA TOXICITY TESTING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ACADEMIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ACADEMIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ACADEMIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PBPK MODELING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PBPK MODELING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PBPK MODELING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY QSAR MODELING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY QSAR MODELING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY QSAR MODELING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CYTOTOXICITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CYTOTOXICITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CYTOTOXICITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ENDOTOXIN TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ENDOTOXIN TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ENDOTOXIN TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY GENOTOXICITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY GENOTOXICITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY GENOTOXICITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHOTOTOXICITY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHOTOTOXICITY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHOTOTOXICITY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ALTERNATIVE ANIMAL MODELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ALTERNATIVE ANIMAL MODELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ALTERNATIVE ANIMAL MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY NONRODENT MODELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY NONRODENT MODELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY NONRODENT MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY RODENT MODELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY RODENT MODELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY RODENT MODELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FERTILIZER MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FERTILIZER MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FERTILIZER MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PESTICIDE MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PESTICIDE MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PESTICIDE MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ESTABLISHED BIOTECHNOLOGY FIRMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ESTABLISHED BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY ESTABLISHED BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY START-UP BIOTECHNOLOGY FIRMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY START-UP BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY START-UP BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COMMODITY CHEMICAL MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COMMODITY CHEMICAL MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COMMODITY CHEMICAL MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SPECIALTY CHEMICAL MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SPECIALTY CHEMICAL MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SPECIALTY CHEMICAL MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COLOR COSMETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COLOR COSMETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COLOR COSMETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY HAIR CARE PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY HAIR CARE PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY HAIR CARE PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SKIN CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SKIN CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SKIN CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BEVERAGE MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BEVERAGE MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BEVERAGE MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY DAIRY PRODUCT MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY DAIRY PRODUCT MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY DAIRY PRODUCT MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PROCESSED FOOD MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PROCESSED FOOD MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PROCESSED FOOD MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY GENERIC PHARMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY GENERIC PHARMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY GENERIC PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY LARGE PHARMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY LARGE PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 235. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 237. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 238. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 239. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 240. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 241. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 242. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 243. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 244. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 245. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 246. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 247. GCC TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 274. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 275. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 276. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 277. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 278. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 279. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 280. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 282. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 283. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 284. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 285. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 286. G7 TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 287. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 288. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 289. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 290. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 291. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 292. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VIVO, 2018-2032 (USD MILLION)
  • TABLE 293. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 294. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY AGROCHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 295. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 296. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY CHEMICAL, 2018-2032 (USD MILLION)
  • TABLE 297. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COSMETIC, 2018-2032 (USD MILLION)
  • TABLE 298. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY FOOD AND BEVERAGE, 2018-2032 (USD MILLION)
  • TABLE 299. NATO TOXICITY TESTING OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL, 2018-2032 (USD MILLION)
  • TABLE 300. GLOBAL TOXICITY TESTING OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY SERVICE PROVIDER, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY TEST MODEL, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN SILICO, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES TOXICITY TESTING OUTSOURCING MARKET SIZE, BY IN VITRO, 2018-2032 (USD MILLION)
  • TABLE 306. UN